These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5510015)

  • 1. Papaverine for cerebral and other vascular disorders.
    Med Lett Drugs Ther; 1970 Mar; 12(6):26-7. PubMed ID: 5510015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ophthalmological use of bencyclane and ophthalmodynamometric recording of its effect on cerebral vessels].
    Födö V
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1450+. PubMed ID: 5536669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency].
    Komorovskaia IaM; Nechaĭ EE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of papaverine on cerebrospinal fluid and blood acid-base balance in patients with vascular diseases of the brain].
    Gabrielian ES; Zograbian SG; Amroian EA; Dadivanian IuP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(8):1168-72. PubMed ID: 973520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cerebral vascular diseases due to softening].
    Tomaselli R; Elia C
    Omnia Med Ther; 1968; 46(3):657-70. PubMed ID: 4989937
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of the effectiveness of papaverine in the long-term therapy of cerebral ischemia].
    Dam M; Battistin L
    Clin Ter; 1981 Dec; 99(5):483-8. PubMed ID: 7333069
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of bencyclane].
    Erczy L
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1414+. PubMed ID: 5536657
    [No Abstract]   [Full Text] [Related]  

  • 9. [Papaverine in high doses in the treatment of cerebral circulatory insufficiency in senescence and senility. (Clinico-statistical study of 474 cases)].
    Ferliga G
    G Gerontol; 1966 Apr; 14(4):345-63. PubMed ID: 5911913
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral ischemia.
    Klinkerfuss GH
    Int Ophthalmol Clin; 1967; 7(4):765-85. PubMed ID: 5607336
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement in brain oxygenation and clinical improvement in patients with strokes treated with papaverine hydrochloride.
    Meyer JS; Gotoh F; Gilroy J; Nara N
    JAMA; 1965 Nov; 194(9):957-61. PubMed ID: 5897963
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of cerebral circulatory insufficiency. Double-blind study of the efficacy of a quinine-papaverine combination].
    Klemm J
    Fortschr Med; 1984 Oct; 102(39):1000-2. PubMed ID: 6389288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
    Hamming JJ; van der Drift JH
    Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations].
    Albot G; Goutmer B; Treps J
    Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study in internal medicine of a drug combination with vascular effects. Apropos of 82 cases using eutergine].
    Albeaux-Fernet M; Romani JD
    Sem Hop; 1968 May; 44(22):1526-8. PubMed ID: 4302769
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative trials of various therapeutics relating to cerebral vessels].
    Brion S; Guérin R
    Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2035-6. PubMed ID: 1101201
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin].
    Gau HP
    Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial of eutergine in chronic cerebral arteriopathies].
    Pauchant M; Bernard JM
    Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.